BridgeMD
Use of a new diagnostic tool in the detection and characterization of endometriosis lesions. ENDO-TEP
EU CTIS ID: 2025-520637-24-00
What this study is testing
The main objective is to study the use of a new diagnostic tool: [18F]-FES PET/CT in the detection and characterisation of endometriosis lesions in association with pain.
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Test: Painful patients with VAS ≥ 4 treated surgically for painful symptoms related to endometriosis
- Control: Patient with VAS < 4 treated surgically for endometriosis in the context of infertility
- Age > 18 years old
- Patient with informed consent
- Patients with preoperative MRI not contraindicated for [18F]-FES PET/CT
- Patient operated on mid-cycle
You likely can't join if
- Patient treated for endometriosis without surgery
- Pregnant patient
- Claustrophobic patient
- Hypersensitivity to the active substance (Fluoroestradiol(18F)) or to one of the excipients
- Patient under legal protection
- Patient taking hormonal treatment
See the full eligibility criteria
- Test: Painful patients with VAS ≥ 4 treated surgically for painful symptoms related to endometriosis
- Control: Patient with VAS < 4 treated surgically for endometriosis in the context of infertility
- Age > 18 years old
- Patient with informed consent
- Patients with preoperative MRI not contraindicated for [18F]-FES PET/CT
- Patient operated on mid-cycle
- Membership of a Social Security scheme
- Patient treated for endometriosis without surgery
- Pregnant patient
- Claustrophobic patient
- Hypersensitivity to the active substance (Fluoroestradiol(18F)) or to one of the excipients
- Patient under legal protection
- Patient taking hormonal treatment
- Menopausal patient
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.